Search hospitals > Minnesota > Princeton
Fairview Northland Medical Center
Claim this profilePrinceton, Minnesota 55371
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Stomach Cancer
Conducts research for Lung Cancer
129 reported clinical trials
10 medical researchers
Summary
Fairview Northland Medical Center is a medical facility located in Princeton, Minnesota. This center is recognized for care of Skin Cancer, Breast Cancer, Cancer, Stomach Cancer, Lung Cancer and other specialties. Fairview Northland Medical Center is involved with conducting 129 clinical trials across 314 conditions. There are 10 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park8 years of reported clinical research
Expert in Skin Cancer
Expert in Non-Small Cell Lung Cancer
104 reported clinical trials
167 drugs studied
Daniel M. AndersonAbbott-Northwestern Hospital6 years of reported clinical research
Expert in Skin Cancer
Expert in Cancer
61 reported clinical trials
110 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Studies Breast Cancer
Studies Skin Cancer
32 reported clinical trials
77 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park6 years of reported clinical research
Studies Cancer
Studies Uterine Tumors
14 reported clinical trials
19 drugs studied
Clinical Trials running at Fairview Northland Medical Center
Breast Cancer
Lung Cancer
Bladder Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Breast cancer
Multiple Myeloma
Bladder Carcinoma
Stomach Cancer
Ovarian Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fairview Northland Medical Center?
Fairview Northland Medical Center is a medical facility located in Princeton, Minnesota. This center is recognized for care of Skin Cancer, Breast Cancer, Cancer, Stomach Cancer, Lung Cancer and other specialties. Fairview Northland Medical Center is involved with conducting 129 clinical trials across 314 conditions. There are 10 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.